Kent Doi

TL;DR: The Surviving Sepsis Campaign (SSC) guidelines provide evidence-based recommendations on the recognition and management of sepsis and its complications as discussed by the authors, which are either strong or weak, or in the form of best practice statements.

TL;DR: The Surviving Sepsis Campaign (SSC) guidelines provide evidence-based recommendations on the recognition and management of sepsis and its complications as mentioned in this paper, which are either strong or weak, or in the form of best practice statements.

TL;DR: This is the first report on nafamostat mesylate treatment in combination with favipiravir against SARS-CoV-2 and the demographic and clinical characteristics and the laboratory and radiologic findings at ICU admission are listed in Table 1.

TL;DR: The evidence gathered was able to formulate Japanese-specific clinical practice guidelines that are tailored to the Japanese context in a highly transparent manner and can easily be used not only by specialists, but also by non-specialists, general clinicians, nurses, pharmacists, clinical engineers, and other healthcare professionals.

TL;DR: The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J‐SSCG 2016), a Japanese‐specific set of clinical practice guidelines for sepsis and septic shock created jointly by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine, was first released in February 2017 in Japanese.